VRTX250620P00300000 Option on Vertex Pharmaceuticals
| VRTX Stock | USD 407.11 1.35 0.33% |
Vertex Pharmaceuticals' latest option contracts expiring on January 10th 2025 are carrying combined implied volatility of 0.71 with a put-to-call open interest ratio of 1.5 over 27 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on January 10th 2025.
Open Interest Against January 10th 2025 Option Contracts
Vertex Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Vertex Pharmaceuticals' lending market. For example, when Vertex Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Vertex Pharmaceuticals, he or she must hedge the risk by shorting Vertex Pharmaceuticals stock over its option's life.
2025-01-10
The chart above shows Vertex Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Vertex Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Vertex Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Vertex Pharmaceuticals
Analyzing Vertex Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Vertex Pharmaceuticals regardless of its overall volatility. This is especially true when Vertex Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Vertex Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Vertex Pharmaceuticals' stock while costing only a fraction of its price.
Vertex Pharmaceuticals In The Money Call Balance
When Vertex Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Vertex Pharmaceuticals stock is said to be in the money. When it comes to buying Vertex Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Vertex Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Vertex Current Options Market Mood
Vertex Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Vertex Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Vertex Pharmaceuticals' options investors are not very successful. Vertex Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Vertex contract
Base on the Rule 16, the options market is currently suggesting that Vertex Pharmaceuticals will have an average daily up or down price movement of about 0.0444% per day over the life of the 2025-01-10 option contract. With Vertex Pharmaceuticals trading at USD 407.11, that is roughly USD 0.18. If you think that the market is fully incorporating Vertex Pharmaceuticals' daily price movement you should consider buying Vertex Pharmaceuticals options at the current volatility level of 0.71%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Vertex |
Purchasing Vertex Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Vertex calls. Remember, the seller must deliver Vertex Pharmaceuticals stock to the call owner when a call is exercised.
Vertex Pharmaceuticals Option Chain
When Vertex Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Vertex Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Vertex Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Vertex. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vertex. It also shows strike prices and maturity days for a Vertex Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | VRTX250110C00250000 | 0 | 250.0 | 216.7 - 224.0 | 216.7 | In |
Call | VRTX250110C00260000 | 0 | 260.0 | 206.9 - 214.0 | 206.9 | In |
Call | VRTX250110C00270000 | 0 | 270.0 | 196.9 - 204.2 | 196.9 | In |
Call | VRTX250110C00280000 | 0 | 280.0 | 187.0 - 194.3 | 187.0 | In |
Call | VRTX250110C00290000 | 0 | 290.0 | 177.1 - 184.4 | 177.1 | In |
Call | VRTX250110C00300000 | 0 | 300.0 | 167.2 - 175.6 | 167.2 | In |
Call | VRTX250110C00310000 | 0 | 310.0 | 157.4 - 164.7 | 157.4 | In |
Call | VRTX250110C00320000 | 0 | 320.0 | 147.5 - 154.7 | 147.5 | In |
Call | VRTX250110C00330000 | 0 | 330.0 | 137.7 - 145.0 | 137.7 | In |
Call | VRTX250110C00340000 | 0 | 340.0 | 127.8 - 134.8 | 127.8 | In |
Call | VRTX250110C00525000 | 3 | 525.0 | 5.8 - 12.7 | 9.65 | Out |
Call | VRTX250110C00530000 | 3 | 530.0 | 5.0 - 11.7 | 8.54 | Out |
Put | VRTX250110P00250000 | 0 | 250.0 | 0.0 - 4.6 | 4.6 | |
Put | VRTX250110P00260000 | 0 | 260.0 | 0.0 - 4.7 | 4.7 | |
Put | VRTX250110P00270000 | 0 | 270.0 | 0.0 - 4.7 | 4.7 | |
Put | VRTX250110P00280000 | 0 | 280.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00290000 | 0 | 290.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00300000 | 0 | 300.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00310000 | 0 | 310.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00320000 | 0 | 320.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00330000 | 0 | 330.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00340000 | 0 | 340.0 | 0.0 - 4.8 | 4.8 | |
Put | VRTX250110P00345000 | 1 | 345.0 | 0.0 - 1.5 | 0.62 | Out |
Put | VRTX250110P00355000 | 1 | 355.0 | 0.0 - 1.5 | 0.65 | Out |
Put | VRTX250110P00400000 | 3 | 400.0 | 0.55 - 7.8 | 4.58 | Out |
Put | VRTX250110P00405000 | 3 | 405.0 | 1.5 - 8.6 | 5.0 | Out |
Put | VRTX250110P00415000 | 1 | 415.0 | 3.5 - 9.9 | 7.3 | Out |
Vertex Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Vertex Total Stockholder Equity
Total Stockholder Equity |
|
Vertex Pharmaceuticals Corporate Management
| Jonathan JD | Executive Officer | Profile | |
| Stephanie Franklin | Senior Officer | Profile | |
| Mike Tirozzi | SVP Officer | Profile | |
| Damian Esq | Chief VP | Profile | |
| Ourania Tatsis | Ex Officer | Profile |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.